Protego Biopharma raises $130M in a series B funding round led by Novartis Venture Fund and Forbion to advance its AL amyloidosis therapy into pivotal trials.
Amount Raised
$130 Million
Round Type
Series B
San DiegoBiotechnologyInvestors
Description
Protego Biopharma has secured $130 million in an oversubscribed series B funding round to advance its lead candidate, PROT-001, into pivotal trials. The round was led by Novartis Venture Fund and Forbion, with support from several new and existing investors. The funding will help Protego progress towards delivering a potential first disease-modifying therapy for AL amyloidosis. This marks a significant step in addressing a rare, life-threatening condition.
Quick answer
Protego Biopharma raised $130 Million in a Series B round, dated December 1, 2025. Investors: MPM BioImpact, Omega Funds, Droia Ventures, YK Bioventures, Digitalis Ventures, Vida Ventures, Lightspeed Venture Partners and Scripps Research. Protego Biopharma is based in San Diego, California, United States.
- How much did Protego Biopharma raise?
- Protego Biopharma raised $130 Million in a Series B round on December 1, 2025.
- Who invested in Protego Biopharma?
- MPM BioImpact, Omega Funds, Droia Ventures, YK Bioventures, Digitalis Ventures, Vida Ventures, Lightspeed Venture Partners and Scripps Research are named as investors in this round.
- What does Protego Biopharma do?
- Protego Bio is a clinical-stage company focused on the discovery and development of first-in-class small-molecule therapeutics that aim to reprogram protein folding for the treatment of various diseases.
- Where is Protego Biopharma based and how big is it?
- Protego Biopharma is based in San Diego, California, United States. Fundz records about 26 employees.
- Who are the decision-makers at Protego Biopharma?
- Fundz holds 3 contacts at Protego Biopharma, including the Chief Science Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Protego Biopharma that raised within 45 days of this round, from Fundz verified event records.
- CRB raised $50M on January 15, 2026.
- Transition Metal Solutions raised $6M (Seed) on January 15, 2026.
- SenseUP raised $3.5M (Seed) on January 15, 2026.
- Cantai Therapeutics raised $3M (Seed) on January 15, 2026.
- Science&Humans raised $7.9M (Series A) on January 15, 2026.
- MARS Bioimaging raised $15M (Series A) on January 14, 2026.
Who to call at Protego Biopharma, and when
A new round usually means Protego Biopharma is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Protego Biopharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Protego Biopharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Protego Biopharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Protego Biopharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansProtego Biopharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.